Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.39 |
| ▸ | FFAR4 | Q5NUL3 | 5/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 4/20 | 0.36 |
| ▸ | CA12 | O43570 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.36 |
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 3/20 | 0.36 |
| ▸ | RARA | P10276 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.36 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17719434 | 0.87 | THRB (0.43) | THRBFFAR4FFAR1APPS1PR1 | |
| SCHEMBL17754285 | 0.87 | PRKAB2 (0.42) | THRBFFAR4FFAR1APPS1PR1 | |
| SCHEMBL9607903 | 0.81 | THRB (0.44) | THRBAPPCA1CA2CYP2C19 | |
| SCHEMBL20672254 | 0.80 | THRB (0.38) | THRBFFAR4FFAR1APPS1PR1 | |
| SCHEMBL9607850 | 0.80 | THRB (0.43) | THRBAPPCYP2C19AKR1C3AKR1C2 | |
| SCHEMBL20998248 | 0.80 | MAOB (0.42) | THRBFFAR4APPCA12CA1 | |
| SCHEMBL19224830 | 0.79 | THRB (0.36) | THRBFFAR4FFAR1APPS1PR1 | |
| SCHEMBL18773562 | 0.78 | CYP2C19 (0.53) | THRBAPPCYP2C19AKR1C3AKR1C2 | |
| SCHEMBL20344357 | 0.78 | APP (0.41) | THRBFFAR1APPCYP2C19AKR1C3 | |
| SCHEMBL15704411 | 0.77 | THRB (0.44) | THRBFFAR4FFAR1AKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | DIC CORPORATION (JP) | 2016-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160137921-A1 | POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION PRODUCED USING SAME | RCC1, LPXN, SMC4 | THRB 4879/4885FFAR4 1131/4885FFAR1 1525/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.